Related Experiment Video
Updated: Jul 14, 2025

Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies
Published on: January 10, 2025
Major Study Affirming the Relative Safety of Testosterone-replacement Therapy
1Professional Compounding Centers of America. bbrxman@aol.com.
Abstract:
Between warnings from the U.S. Food and Drug Administration and many articles being published with the consensus that testosterone-replacement therapy had an increased cardiovascular risks in men, thereby questioning the relative safety of the therapy, the needs of hypogonadal (low testosterone) men, who also present with symptoms related to this condition, are much less likely to receive a treatment that can significantly improve their quality of life. This article discusses a major research project that determined that testosterone replacement therapy was no worse than a placebo in men with cardiovascular disease or at high risk for cardiovascular disease.
Insights
Testosterone replacement therapy is safe for men with low testosterone and cardiovascular disease. A major study found it poses no greater cardiovascular risk than a placebo.
Area of Science:
- Cardiovascular Science
- Endocrinology
- Men's Health
Background:
- Concerns exist regarding cardiovascular risks of testosterone replacement therapy (TRT).
- Hypogonadal men with symptoms are often undertreated due to safety concerns.
- Existing research has yielded conflicting results on TRT's cardiovascular safety.
Purpose of the Study:
- To evaluate the cardiovascular safety of TRT in men with established cardiovascular disease or at high risk.
- To determine if TRT increases adverse cardiovascular events compared to placebo.
Main Methods:
- A large-scale research project involving men with cardiovascular disease or high cardiovascular risk.
- Comparison of TRT group versus placebo group.
- Monitoring of major adverse cardiovascular events.
Main Results:
- Testosterone replacement therapy was found to be non-inferior to placebo regarding cardiovascular safety.
- No significant increase in cardiovascular events was observed in men receiving TRT.
- The therapy did not worsen outcomes for men with pre-existing cardiovascular conditions.
Conclusions:
- TRT can be considered a safe option for hypogonadal men with cardiovascular disease or at high risk.
- The study alleviates concerns about TRT's cardiovascular safety in this patient population.
- This finding supports improved quality of life for hypogonadal men through safe TRT.
More Related Videos
11:51Combining Behavioral Endocrinology and Experimental Economics: Testosterone and Social Decision Making
Published on: March 2, 2011
07:25A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
Related Concept Videos
Testosterone: Functions and Regulation
Disorders of the Male Reproductive System
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
Regression Toward the Mean
Electroconvulsive Therapy
Hormonal Regulation